Literature DB >> 4075619

Treatment of neoplastic disease during pregnancy: maternal and fetal effects.

S B Sutcliffe.   

Abstract

A review of the factors involved in treating the cancer patient during pregnancy is presented with respect to the fetus and the mother. The fetus may be adversely affected by diagnostic procedures, radiation therapy, cytotoxic chemotherapy or by the mother's metastatic disease or diminished health. Prenatal consideration must be given to the mother's additional nutritional requirements, susceptibility to infection, the effect of cancer therapies on blood counts and likelihood of hemorrhage. Postpartum and postnatal treatment should include cancer assessment, contraceptive and genetic counselling and long term follow-up of progeny.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075619

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  4 in total

1.  Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence.

Authors:  M Lishner; G Koren
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

Review 2.  Creating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patients.

Authors:  Betty Y Kong; Robin M Skory; Teresa K Woodruff
Journal:  Clin Obstet Gynecol       Date:  2011-12       Impact factor: 2.190

Review 3.  Fetal outcome after maternal radiation treatment of supradiaphragmatic Hodgkin's disease.

Authors:  E Friedman; G W Jones
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

Review 4.  Treating breast cancer during pregnancy. What can be taken safely?

Authors:  M Espié; C Cuvier
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.